Solutia (SOA) To Discontinue Manufacturing at its Plant in Cologne, Germany
More News related to SOA
- Sidoti & Co Initiates Coverage on Solutia (SOA) with a Buy
- Solutia to Present at Deutsche Bank Small and Mid Cap Conference
- Innovative Exterior Films Improve Windows Outside and In
- CPFilms Launches New Websites Supporting Premium Brands
- Morning Movers 1/28: PFBC, NFLX, ESIO, MEG, EK, ETRM Higher; KSP, TTEK, QCOM, CTS, LSI Lower
More News related to Corporate News
- Quaterra Resources (QMM) and Goldcorp (GG) Enter Binding Investment Framework Agreement
- Curis (CRIS) Announces Publication of CUDC-101 Data
- Trina Solar Limited (TSL) Announces Breakthrough in Monocrystalline Cell Development
- Cavico (CAVO) Signs Additional Contract at Nua Na Hydropower Plant; Expects Revs of $11.9M
- YM BioSciences (YMI) Receives Two Patents for AeroLEF Acute and Severe Pain Treatment
Solutia Inc. (NYSE: SOA) announced it will discontinue manufacturing at its plant in Cologne, Germany, effective as soon as practical. Taminco N.V. will acquire certain assets and assume certain contracts and commercial obligations relating to the tetramethylthiuram disulfide (TMTD) and tetraethylthiuram disulfide (TETD) products. As a part of that transaction, Solutia will continue to produce TMTD and TETD at Cologne for Taminco during a transition period, which is expected to conclude by the end of the first quarter 2010. Solutia will continue to manufacture and provide Perkacit DPTT to customers.
"Due to the emergence of lower cost competition, the TMTD and TETD products manufactured by Solutia at Cologne are no longer competitive on a global scale," said Mike Donnelly, president and general manager, for Solutia's Technical Specialties business.
[SM]
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
